Azaibi Tamin

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 and multiple endemic, epidemic and bat coronavirus

Alexandra Schäfer, Ralph S. Baric, Amy C. Sims, 2020, bioRxiv.

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association.

Wenhui Li, W. Bellini, W. Marasco, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient

Shinji Makino, Brian Lynch, Scott C. Weaver, 2020, bioRxiv.

Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

Christian Drosten, Larry J. Anderson, Brian Holloway, 2003, Science.

Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1

James O. Lloyd-Smith, Dylan H. Morris, Amandine Gamble, 2020, medRxiv.

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

Xiaotao Lu, Alexandra Schäfer, Ralph S. Baric, 2020, Science Translational Medicine.